在线客服: 点击这里给我发消息  新用户使用步骤:会员注册→充值→重新登入→进入资源
标题:Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia.
时间:2018-12-07 07:46:48
DOI:10.1038/bmt.2017.237
PMID:29334367
作者:LP Xu;ZL Xu;FR Wang;XD Mo;TT Han
出版源: 《Bone Marrow Transplant》 ,2018
摘要:Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemiaAbstract We conducted a retrospective analysis to evaluate outcomes of haploidentical transplantation in ...
大小:304 kb
下载: 点击下载
预览:

浏览器不支持嵌入PDF阅读,打开新页面在线阅读

目录:
  • Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia
    • Introduction
    • Subjects and methods
      • Patients
      • Transplantation procedures
      • Definition and evaluation
      • Statistical analysis
    • Results
      • Basic characteristics of the patient cohort
    • Table 1 Patient and graft characteristics
      • Engraftment and GvHD
      • Early viral infection (⩽100’days)
      • Regimen-related toxicity and transplantation-related mortality
      • Survival outcomes
      • Risk factors for survival and GvHD
    • Discussion
    • Table 2 Multivariate analysis of adverse factors associated with survival outcomes
    • Figure 1 Kaplan–Meier estimates of OS (FFS) according to HCT-CI scores (0–2 vs ⩾€3).
    • This work was partly supported by Collaborative Innovation Centre of Haematology China, National Natural Science Foundation of China (Grant No. 81230013 and 81370666) and Beijing Municipal Science & Technology Commission (No. Z141100000214011 and Z1511000
    • This work was partly supported by Collaborative Innovation Centre of Haematology China, National Natural Science Foundation of China (Grant No. 81230013 and 81370666) and Beijing Municipal Science & Technology Commission (No. Z141100000214011 and Z1511000
    • ACKNOWLEDGEMENTS
    • REFERENCES

本页内容由网络收集而来,版权归原创者所有,如有侵权请及时联系